Pilot Study of Sodium Nitrite in Resuscitated Cardiac Arrest Patients
Completed · Phase 1
Conditions studied: Cardiac Arrest
In brief
Despite advances in cardiac arrest resuscitation survival from cardiac arrest is less than 20-30% and new therapies are urgently needed. Sodium nitrite infused during resuscitation from cardiac arrest has recently been shown to improve survival in a mouse model of cardiac arrest and our group is eager to test this hypothesis in a clinical trial. Our overall hypothesis is that an infusion of 2 μmole/kg sodium nitrite during resuscitation will increase the proportion of patients who will survive cardiac arrest. In preparation for a clinical trial, preliminary safety and efficacy data (phase 1) is needed which is the primary goal of this study.
Key facts
- Study ID
- NCT01178359
- Run by
- University of Washington
- People needed
- 11
- Starts
- 2010-01-01
- Expected to finish
- 2016-04-01
- Last updated by the study team
- 2017-05-18
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Successfully resuscitated from cardiac arrest by paramedics in the field Age 18 or older Comatose IV access
You may not qualify if…
- traumatic cause of cardiac arrest known DNAR Patient requiring vasopressors at time of randomization SBP <105 PaO2 of less than 90% on FiO2 of 1.0
Where it is running
- Harborview Medical Center — Seattle, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.